Wednesday, September 07, 2005

 

Biolex raises $36 million in venture capital

Biolex announced September 1 the completion of another round of venture capital funding. According to the press release, this funding round will be used among other things, to expand their cGMP manufacturing capabilities. Biolex has been on a roll recently, announcing their acquisition of Lemnagene in July and a partnership with Centocor in March.
|


<< Home





This page is powered by Blogger. Isn't yours?